• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

cholesterol drug

recall
Manufacturing

Orient Pharma, AvKARE recall some 80K bottles of cholesterol med

Drugmakers Orient Pharma and AvKARE have launched separate recalls of the cholesterol drug pitavastatin in the U.S. over impurity concerns.
Joseph Keenan Jul 23, 2025 8:32am
verdict damages punitive damages compensatory damages lawsuit

Amgen owes Regeneron $407M after defeat in PCSK9 antitrust suit

May 15, 2025 3:52pm
Daiichi

Daiichi blasts 'malicious and defamatory' marketing complaints

Feb 21, 2024 9:25am
Daiichi

Daiichi press release found to discredit pharma on safety basis

Nov 8, 2023 9:00am
Cholesterol

Amgen launches 'Lower Your LDL Cholesterol Now' campaign

Aug 29, 2023 9:35am
Regeneron

FDA says children age 5-11 now eligible for Regeneron's Evkeeza

Mar 22, 2023 10:39am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings